Recent insider trends for Kitov Pharmaceuticals Holdings Ltd. (NASDAQ:KTOV) have caught the attention of investors. Insider data is useful because it can reveal what a company’s executives and largest shareholders feel about a stock. In this case, the data has some interesting things to say about how KTOV might perform in the future.
Institutions own 01.97% of Kitov Pharmaceuticals Holdings Ltd. (KTOV)’s shares. The total value of these holdings, in millions, is $1. Among active positions in the latest quarter, 2 holders increased their positions by a total of 35376 shares, 5 holders decreased the positions by a total of 27337 shares, and 1 holders held their positions. This works out to a net increase in ownership of 8039 shares, and suggests that institutions are feeling bullish about the stock.
Among new and sold out positions, 0 holders initiated new positions by a total of 0 shares and 1 holders exited their positions by a total of 10900 shares. This nets out to a decrease of 10900 shares and is another bearish sign for KTOV.
Insider ownership increased by a total of 0 shares, which suggests that KTOV’s key executives are feeling more optimistic about the outlook for the stock. The data from the past twelve months tells a similar story: ownership increased by a net of 0 shares.
The analysis of insider buying and selling trends can be extended to the aggregate level. Short interest, which represents the number of a stock’s shares currently being shorted, captures what the market as a whole feels about a stock. Kitov Pharmaceuticals Holdings Ltd. (NASDAQ:KTOV)’s short interest is 322400 shares, or 4.34% of the float. This represents a decrease of -12% in the number of shares being shorted compared to the previous reading, and implies that investors felt less pessimistic about the stock during the past two weeks.
Supplementing insider data with technical indicators can help an investor form a more complete view on the outlook for a stock. A composite of 13 technical indicators that includes measures such as moving averages and momentum oscillators suggests that KTOV is a Strong buy, which implies that KTOV is expected to outperform the market based on prior trading patterns.
Institutional ownership trends suggest that the stock is cheap and the insider trading data indicates that insiders are bullish. Technical indicators (also) suggest that Kitov Pharmaceuticals Holdings Ltd. (NASDAQ:KTOV) is undervalued.